Using of lactate dehydrogenase and Gamma glutamyl transpeptidase as routine screening test among patients with breast cancer

A Ahmed Zahra; Elkareem A Rabo Abd; Ma. Babker Asaad

doi:10.30574/gscbps.2019.9.3.0229

Authors

A Ahmed Zahra Department of Clinical Chemistry, Faculty of Medical Laboratory Sciences, University of Al-Neelain, Khartoum, Sudan.
Elkareem A Rabo Abd Department of Clinical Chemistry, Faculty of Medical Laboratory Sciences, University of Al-Neelain, Khartoum, Sudan.
Ma. Babker Asaad Department of Medical Laboratory Sciences, College of Health Sciences, Gulf Medical University, Ajman, UAE.

DOI:

https://doi.org/10.30574/gscbps.2019.9.3.0229

Keywords:

Lactate dehydrogenase, Gamma glutamyl transpeptidase, Breast cancer, Screaming test

Abstract

Breast cancer is cancer that forms in the cells of the breasts. After skin cancer, breast cancer is the most common cancer diagnosed in women in the United States. Breast cancer can occur in both men and women, but it's far more common in women. Aim of this study to evaluate the lactate dehydrogenase and Gamma glutamyl transpeptidase as screening tests among women with breast cancer. Fifty women diagnosed with breast cancer were involved in this cross-sectional study, they were attended to Khartoum oncology hospital for diagnosis, treatment and follow up. They were grade I, II and III. Approval of study to be performed was obtained from each patient and hospital administration as well. Under hygienic condition blood withdrawn in plane containers from each subject considering labeling and data obtained from each one, blood allowed for clot formation and subsequent serum separation which preserved at -20 ℃ for later chemical analysis. Chemical analysis targeted enzymes, GGT, LDH and ALP, they measured by means of spectrophotometer method, using Biosystem device, reagents were Biosystem trademark, they were ready to use. This study conducted in concern of breast cancer, it involved 50 women with established diagnosis, the Mean±SD duration of the disease was (3.52+1.89) years and their age Mean±SD was (38.1+6.31) year’s .They were enrolled in the measurement of GGT and LDH Comparing the levels of measured parameters with normal value for each one, brought significant difference for LDH and ALP. Enzymes level among the three grades of breast cancer brought significant difference for LDH at grade II and III as p values 0.022 and 0.001 respectively, while GGT has only significant difference at grade III as p value 0.022. Significant elevation in serum levels of lactate dehydrogenase and Gamma glutamyl transpeptidase among patients with breast cancer and suggest that the estimation of both can be used as routine screening tests in all suspected carcinoma breast patients.

Metrics

Metrics Loading ...

References

Joe BN. Clinical features, diagnosis, and staging of newly diagnosed breast cancer.

Siegel RL, Miller KD and Jemal A. (2019). Cancer statistics, CA Cancer J Clin, 69, 7.

Laronga C, Chagpar AB and Vora SR. (2016). Patient education: breast cancer guide to diagnosis and treatment (beyond the basics). UpToDate. UpToDate, Waltham, 7.

Parkin DM, Bray F, Ferlay J and Pisani P. (2002). Global cancer statistics, CA Cancer J Clin, 55(2), 74–108.

Beral V. (2003). Million Women Study Collaborators Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet, 362, 419–427.

Layde PM, Webster LA, Baughman AL, Wingo PA, Rubin GL and Ory HW. (1989).The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group. J Clin Epidemiol, 42, 963–973.

Hirschhaeuser F, Sattler UGa and Mueller-Klieser W. (2011). Lactate: a metabolic key player in cancer. Cancer Res, 71, 6921–6925.

Maekawa M, Taniguchi T, Ishikawa J, Sugimura H, Sugano K and Kanno T. (2003). Promoter hypermethylation in cancer silences LDHB, eliminating lactate dehydrogenase isoenzymes 1-4. Clin Chem, 49, 1518–1520.

Balch CM, Soong S, Atkins MB, Buzaid AC, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA and Thompson JF. (2004). An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 54, 131–149, quiz 182–184.

Barlow LJ, Badalato GM. (2010). McKiernan JM Serum tumor markers in the evaluation of male germ cell tumors. Nat Rev Urol, 7, 610–617.

Kazemi-Shirazi L, Endler G, Winkler S, Schickbauer T, Wagner O and Marsik C. (2007). Gamma glutamyltransferase and long-term survival: is it just the liver? Clin Chem, 53(5), 940–6.

Whitfield JB. (2001). Gamma glutamyl transferase. Crit Rev Clin Lab Sci, 38(4), 263–355.

Li S, Tan HY, Wang N, Zhang ZJ, Lao L, Wong CW and Feng Y. (2015). The role of oxidative stress and antioxidants in liver diseases. International journal of molecular sciences, 16(11), 26087-124.

Zahra A. Ahmed, Abd Elkareem A. Rabo, Nagla Abdalhafez Mohamed and Asaad Ma. Babker. (2019). Assessment of the Activity of Lactate Dehydrogenase, Gamma Glutamyl Transpeptidase and Alkaline Phosphatase in Carcinoma Breast. EUROPEAN JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCH, 6(12), 55-58.

Duffy MJ. (2001). Biochemical markers in breast cancer: which ones are clinically useful?. Clinical biochemistry, 1, 34(5), 347-52.

Mehdi M, Menon MKC, Seyoum N, Bekele M, Tigeneh W and Seifu D. (2018). Blood and Tissue Enzymatic Activities of GDH and LDH, Index of Glutathione, and Oxidative Stress among Breast Cancer Patients Attending Referral Hospitals of Addis Ababa, Ethiopia: Hospital-Based Comparative Cross-Sectional Study. Oxidative medicine and cellular longevity.

Talaiezadeh A, Shahriari A, Tabandeh MR, Fathizadeh P and Mansouri S. (2015). Kinetic characterization of lactate dehydrogenase in normal and malignant human breast tissues. Cancer Cell International, 15(1), 19.

Miao P, Sheng S, Sun X, Liu J and Huang G. (2013). Lactate dehydrogenase A in cancer: a promising target for diagnosis and therapy. IUBMB life, 65(11), 904-910.

Fentiman IS and Allen DS. (2010). γ-Glutamyl transferase and breast cancer risk. British journal of cancer, 103(1), 90.

McElroy JA, Shafer MM, Trentham-Dietz A, Hampton JM and Newcomb PA. (2006). Cadmium exposure and breast cancer risk. J Natl Cancer Inst, 98, 869–873.

Basnyat AS, Jha A, Pathak R, Shrestha BG. (2017). Study of Serum Lactate Dehydrogenase and Gamma-Glutamyl Transpeptidase in Breast Cancer Patients receiving Chemotherapy. Journal of Tropical Life Science, 9, 7(2), 128-32.

Rajeswari G, Srinivas PS, Krishna Sai, KSR and Suresh E. (2016). Study of serum LDH and GGT levels in carcinoma breast. International Journal of Biomedical and Advance Research, 7(1), 31-34.